In conclusion, overexpression of binding-defective CRLF1 variants sensitizes ovarian cancer cells to DDP-induced pyroptosis by competitively inhibiting the AKT-SIN1 interaction and reducing AKT phosphorylation. Here, CRLF1 is linked to ovarian carcinoma.